- Ocular Therapeutix (OCUL, Financial) shares surged 6% amid acquisition rumors.
- Analysts project a potential upside of 31.82% from current prices.
Shares of Ocular Therapeutix (OCUL) experienced a notable uptick, rising 6% due to swirling rumors of a prospective acquisition by a prominent French pharmaceutical company. Industry insiders highlighted a Betaville alert, hinting at a lucrative purchase price of $16 per share, with an additional $2 Contingent Value Right. Interestingly, this speculation coincides with Ocular's participation in the Baird Global Health Conference today.
https://www.gurufocus.com/news/3096749/ocular-therapeutix-ocul-surges-amid-takeover-speculation
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.